You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR CLORAZEPATE DIPOTASSIUM


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for CLORAZEPATE DIPOTASSIUM

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00775996 ↗ Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions Completed Ranbaxy Laboratories Limited N/A 2003-08-01 The objective of this study was to compare the single-dose relative bioavailability of Ranbaxy and Abbott (TranxeneeT-Tab®) 15 mg clorazepate dipotassium tablets under fasting conditions.
NCT04726592 ↗ Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room Recruiting Assistance Publique - Hôpitaux de Paris Phase 3 2021-07-08 The purpose of this study is to evaluate the efficacy of clorazepate in addition to the usual medication for treating migraine attack in the emergency room
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for CLORAZEPATE DIPOTASSIUM

Condition Name

Condition Name for CLORAZEPATE DIPOTASSIUM
Intervention Trials
Migraine Without Aura 1
Headache 1
Healthy 1
Migraine 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for CLORAZEPATE DIPOTASSIUM
Intervention Trials
Migraine without Aura 1
Migraine with Aura 1
Migraine Disorders 1
Headache 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for CLORAZEPATE DIPOTASSIUM

Trials by Country

Trials by Country for CLORAZEPATE DIPOTASSIUM
Location Trials
France 1
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for CLORAZEPATE DIPOTASSIUM
Location Trials
Nebraska 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for CLORAZEPATE DIPOTASSIUM

Clinical Trial Phase

Clinical Trial Phase for CLORAZEPATE DIPOTASSIUM
Clinical Trial Phase Trials
Phase 3 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for CLORAZEPATE DIPOTASSIUM
Clinical Trial Phase Trials
Completed 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CLORAZEPATE DIPOTASSIUM

Sponsor Name

Sponsor Name for CLORAZEPATE DIPOTASSIUM
Sponsor Trials
Ranbaxy Laboratories Limited 1
Assistance Publique - Hôpitaux de Paris 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for CLORAZEPATE DIPOTASSIUM
Sponsor Trials
Other 1
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.